BioTelemetry, Inc.
(NASDAQ : BEAT)

( )
BEAT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-2.43%79.770.6%$370.99m
ISRGIntuitive Surgical, Inc.
-1.00%986.677.5%$322.77m
TMOThermo Fisher Scientific Inc.
-0.55%175.811.0%$280.99m
BDXBecton, Dickinson and Company
-1.36%197.641.3%$238.49m
ABTAbbott Laboratories
-0.12%49.650.8%$233.47m
ALGNAlign Technology, Inc.
0.17%172.856.2%$184.18m
ZBHZimmer Biomet Holdings, Inc.
-1.47%112.291.7%$181.10m
SYKStryker Corporation
-4.93%138.341.3%$171.03m
EWEdwards Lifesciences Corporation
-1.32%112.711.2%$152.82m
BCRC. R. Bard, Inc.
-0.46%318.761.6%$152.56m
BAXBaxter International Inc.
-1.11%61.461.7%$145.74m
HOLXHologic, Inc.
-1.09%37.191.6%$143.77m
BSXBoston Scientific Corporation
-1.36%26.841.1%$140.72m
XRAYDENTSPLY International Inc.
-0.88%53.223.0%$104.27m
DXCMDexCom, Inc.
-0.95%75.198.7%$101.27m

Company Profile

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The company also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through operates through three segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.